HSA
CRBU icon

HBK Sorce Advisory’s Caribou Biosciences CRBU Stock Holding History

HBK Sorce Advisory’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.9K Hold
12,344
– – ﹤0.01% 650
2025
Q4 		$19.4K Hold
12,344
– – ﹤0.01% 621
2025
Q3 		$35.1K Hold
12,344
– – ﹤0.01% 609
2025
Q2 		$15.6K Buy
+12,344
New +$12.1K ﹤0.01% 587

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Sorce Advisory's CRBU Position: Q1 2026 in Review

HBK Sorce Advisory held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 12,344 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

HBK Sorce Advisory first reported a position in CRBU in Q2 2025 and has held it in 4 quarters since. The position peaked at $35.1K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • HBK Sorce Advisory held 12,344 shares of Caribou Biosciences worth $23.9K as of Q1 2026.
  • HBK Sorce Advisory left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #650 holding.
  • HBK Sorce Advisory first reported a position in Caribou Biosciences in Q2 2025 and has held it in 4 quarters since.
  • HBK Sorce Advisory's Caribou Biosciences position peaked at $35.1K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.